BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 14586385)

  • 1. Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics.
    Gashaw I; Kirchheiner J; Goldammer M; Bauer S; Seidemann J; Zoller K; Mrozikiewicz PM; Roots I; Brockmöller J
    Clin Pharmacol Ther; 2003 Nov; 74(5):448-57. PubMed ID: 14586385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression.
    Pinto AG; Wang YH; Chalasani N; Skaar T; Kolwankar D; Gorski JC; Liangpunsakul S; Hamman MA; Arefayene M; Hall SD
    Clin Pharmacol Ther; 2005 Mar; 77(3):178-88. PubMed ID: 15735612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction.
    Haas CE; Brazeau D; Cloen D; Booker BM; Frerichs V; Zaranek C; Frye RF; Kufel T
    Eur J Clin Pharmacol; 2005 Sep; 61(8):583-93. PubMed ID: 16041547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2C19 genotype affects diazepam pharmacokinetics and emergence from general anesthesia.
    Inomata S; Nagashima A; Itagaki F; Homma M; Nishimura M; Osaka Y; Okuyama K; Tanaka E; Nakamura T; Kohda Y; Naito S; Miyabe M; Toyooka H
    Clin Pharmacol Ther; 2005 Dec; 78(6):647-55. PubMed ID: 16338280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin.
    Kerbusch T; Jansen RL; Mathôt RA; Huitema AD; Jansen M; van Rijswijk RE; Beijnen JH
    Clin Pharmacol Ther; 2001 Aug; 70(2):132-41. PubMed ID: 11503007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous assessment of CYP3A4 and CYP1A2 activity in vivo with alprazolam and caffeine.
    Schmider J; Brockmöller J; Arold G; Bauer S; Roots I
    Pharmacogenetics; 1999 Dec; 9(6):725-34. PubMed ID: 10634135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of cytochrome P450 (CYP) 3A5 polymorphisms on the pharmacokinetics of lansoprazole enantiomers in CYP2C19 extensive metaboliser renal transplant recipients.
    Miura M; Inoue K; Satoh S; Itoh Y; Kagaya H; Tada H; Tanaka Y; Habuchi T; Suzuki T
    Clin Drug Investig; 2007; 27(4):251-8. PubMed ID: 17358097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship between single-oral dose kinetics of alprazolam and cytochrome P4503A and cytochrome P4502C19].
    Yasui N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):109-12. PubMed ID: 8905799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of multidrug resistance-1 and cytochrome P450 mRNAs in human mononuclear cells by rifampin.
    Asghar A; Gorski JC; Haehner-Daniels B; Hall SD
    Drug Metab Dispos; 2002 Jan; 30(1):20-6. PubMed ID: 11744607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical role of cytochrome p450 genotypes in Helicobacter pylori management.
    Sapone A; Vaira D; Trespidi S; Perna F; Gatta L; Tampieri A; Ricci C; Cantelli-Forti G; Miglioli M; Biagi GL; Paolini M
    Am J Gastroenterol; 2003 May; 98(5):1010-5. PubMed ID: 12809821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triazolam is ineffective in patients taking rifampin.
    Villikka K; Kivistö KT; Backman JT; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Jan; 61(1):8-14. PubMed ID: 9024169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo modulation of CYP enzymes by quinidine and rifampin.
    Branch RA; Adedoyin A; Frye RF; Wilson JW; Romkes M
    Clin Pharmacol Ther; 2000 Oct; 68(4):401-11. PubMed ID: 11061580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.
    Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK
    Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype.
    Lamba J; Strom S; Venkataramanan R; Thummel KE; Lin YS; Liu W; Cheng C; Lamba V; Watkins PB; Schuetz E
    Clin Pharmacol Ther; 2006 Apr; 79(4):325-38. PubMed ID: 16580901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of recombinant enzyme kinetics in prediction of human clearance: impact of variability, CYP3A5, and CYP2C19 on CYP3A4 probe substrates.
    Galetin A; Brown C; Hallifax D; Ito K; Houston JB
    Drug Metab Dispos; 2004 Dec; 32(12):1411-20. PubMed ID: 15342470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers.
    Markowitz JS; Donovan JL; Devane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
    Clin Pharmacol Ther; 2003 Dec; 74(6):536-42. PubMed ID: 14663456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women.
    Floyd MD; Gervasini G; Masica AL; Mayo G; George AL; Bhat K; Kim RB; Wilkinson GR
    Pharmacogenetics; 2003 Oct; 13(10):595-606. PubMed ID: 14515058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module.
    Goodwin B; Hodgson E; Liddle C
    Mol Pharmacol; 1999 Dec; 56(6):1329-39. PubMed ID: 10570062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative RT-PCR for CYP3A4 mRNA in human peripheral lymphocytes: induction of CYP3A4 in lymphocytes and in liver by rifampicin.
    Nakamoto T; Hase I; Imaoka S; Hiroi T; Oda Y; Asada A; Funae Y
    Pharmacogenetics; 2000 Aug; 10(6):571-5. PubMed ID: 10975612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.